MedPath
NMPA Approval

Dabigatran Etexilate Capsules

国药准字H20244408

October 15, 2024

Drug Information

达比加群酯胶囊

胶囊剂

110mg(以达比加群酯计)

化学药品

October 15, 2024

Company Information

Applicant Company

吉林省梅河口市梧桐路1888号,吉林省梅河口市湘江路66号(一照多址)

Manufacturing Company

吉林省梅河口市湘江路66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达比加群酯胶囊 - NMPA 批准文号 | MedPath